Effect of Nicotine Pouches on The Underlying Normal Electrocardiogram
Launched by EKIM SEVEN · Jul 4, 2025
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18-70 years.
- • Regular (defined as daily) or occasional (generally defined as nondaily) nicotine users (e.g., cigarettes, vaping, or nicotine pouches).
- • Willingness to abstain from nicotine, caffeine (including caffeine containing energy drinks), and alcohol for 6 hours prior to the session
- Exclusion Criteria:
- • History of cardiovascular conditions.
- • Medications affecting cardiac conduction or autonomic function (e.g., antiarrhythmic drugs).
- • Pregnancy or breastfeeding.
- • Current illness or infection.
- • History of substance abuse.
About Ekim Seven
Ekim Seven is a clinical trial sponsor dedicated to advancing medical research through the development and support of innovative clinical studies. Committed to scientific excellence and patient-centered approaches, Ekim Seven collaborates with healthcare professionals and research institutions to facilitate the discovery of new therapies and improve health outcomes across diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hvidovre, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported